US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
SNDK
$1,704.16
▼-0.92%
AAPL
$332.89
▼-0.24%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Chemed Corp
(NY:
CHE
)
511.30
+3.80 (+0.75%)
Official Closing Price
Updated: 4:10 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Chemed Corp
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
October 01, 2026
From
Chemed Corp.
Via
GlobeNewswire
3 Small-Cap Stocks with Questionable Fundamentals
October 01, 2026
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Via
StockStory
Roto-Rooter Buys Largest Franchisee Territory
September 16, 2026
From
Chemed Corp.
Via
GlobeNewswire
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
September 08, 2026
From
Chemed Corp.
Via
GlobeNewswire
Chemed Corp (NYSE:CHE) High Growth Stock Surges on Earnings Beat and Raised Guidance
↗
July 28, 2026
Via
Chartmill
Topics
Earnings
Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040
↗
September 05, 2026
The insider sold 1,000 shares but still holds nearly 14,000 shares.
Via
The Motley Fool
Topics
Regulatory Compliance
CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation’s Directors and Officers for Breach of Fiduciary Duties – CHE
September 03, 2026
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation’s Directors and Officers for Breach of Fiduciary Duties – CHE
August 20, 2026
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
1 Cash-Producing Stock with Exciting Potential and 2 Facing Challenges
August 12, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
1 Momentum Stock for Long-Term Investors and 2 We Brush Off
August 11, 2026
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...
Via
StockStory
1 Small-Cap Stock to Target This Week and 2 We Brush Off
August 07, 2026
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Via
StockStory
Chemed Corporation Declares Quarterly Dividend of 70 Cents
August 06, 2026
From
Chemed Corp.
Via
GlobeNewswire
5 Insightful Analyst Questions From Chemed’s Q2 Earnings Call
August 04, 2026
Chemed’s Q2 results exceeded Wall Street’s expectations, prompting a positive response from investors. Management attributed the performance primarily to str...
Via
StockStory
Topics
Earnings
Chemed Q2 Earnings Call Highlights
↗
July 29, 2026
Chemed (NYSE:CHE) reported second-quarter 2026 results marked by stronger-than-expected performance at its VITAS hospice business, while Roto-Rooter delivered revenue growth but continued to face...
Via
MarketBeat
Topics
Earnings
Economy
CHE Q2 Deep Dive: VITAS Growth and Roto-Rooter Marketing Pressures Shape Outlook
July 29, 2026
Healthcare services company Chemed Corporation (NYSE:CHE) announced better-than-expected revenue in Q2 CY2026, with sales up 8.8% year on year to $673.3 mill...
Via
StockStory
Chemed (NYSE:CHE) Exceeds Q2 CY2026 Expectations
July 28, 2026
Healthcare services company Chemed Corporation (NYSE:CHE) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 8.8% year on year ...
Via
StockStory
Chemed Reports Second-Quarter 2026 Results
July 28, 2026
Full-Year Guidance Increased Due Mainly to VITAS Outperformance
From
Chemed Corp.
Via
GlobeNewswire
Chemed (CHE) Q2 Earnings: What To Expect
July 26, 2026
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting earnings this Tuesday after market close. Here’s what to look for. Chemed beat an...
Via
StockStory
3 Healthcare Stocks We Keep Off Our Radar
July 24, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have...
Via
StockStory
3 Unpopular Stocks We’re Skeptical Of
July 21, 2026
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...
Via
StockStory
Topics
Economy
3 Reasons to Sell CHE and 1 Stock to Buy Instead
July 21, 2026
Chemed trades at $513.71 and has moved in lockstep with the market. Its shares have returned 13.3% over the last six months while the S&P 500 has gained 8.4%...
Via
StockStory
Topics
Artificial Intelligence
Stocks
Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29
July 01, 2026
From
Chemed Corp.
Via
GlobeNewswire
A Look Back at Senior Health, Home Health & Hospice Stocks’ Q1 Earnings: Chemed (NYSE:CHE) Vs The Rest Of The Pack
June 21, 2026
Looking back on senior health, home health & hospice stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) an...
Via
StockStory
Topics
Economy
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
June 18, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
1 Profitable Stock for Long-Term Investors and 2 We Avoid
June 10, 2026
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via
StockStory
Roto-Rooter Buys Franchise Territory in Corpus Christi, Rio Grande Valley, and Beaumont, Texas
June 08, 2026
From
Chemed Corp.
Via
GlobeNewswire
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
May 18, 2026
From
Chemed Corp.
Via
GlobeNewswire
2 Small-Cap Stocks with Solid Fundamentals and 1 We Avoid
May 18, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via
StockStory
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference
May 13, 2026
From
Chemed Corp.
Via
GlobeNewswire
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026
May 05, 2026
From
Chemed Corp.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
